Cargando…

Spatial Navigation and Its Association With Biomarkers and Future Dementia in Memory Clinic Patients Without Dementia

BACKGROUND AND OBJECTIVES: Impaired spatial navigation is considered an early sign in many neurodegenerative diseases. We aimed to determine whether spatial navigation was associated with future dementia in patients with subjective cognitive decline (SCD) or mild cognitive impairment (MCI) and to ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tangen, Gro Gujord, Nilsson, Maria H., Stomrud, Erik, Palmqvist, Sebastian, Hansson, Oskar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651458/ https://www.ncbi.nlm.nih.gov/pubmed/36028328 http://dx.doi.org/10.1212/WNL.0000000000201106

Ejemplares similares

The Effects of Tau, Amyloid, and White Matter Lesions on Mobility, Dual Tasking, and Balance in Older People
por: Nilsson, Maria H, et al.
Publicado: (2020)

Associations Between CSF Markers of Inflammation, White Matter Lesions, and Cognitive Decline in Individuals Without Dementia
por: Gertje, Eske Christiane, et al.
Publicado: (2023)

Associations between Cognition and Hand Function in Older People Diagnosed with Mild Cognitive Impairment or Dementia
por: Hesseberg, Karin, et al.
Publicado: (2020)

A Longitudinal Study of Physical Function in Patients with Early-Onset Dementia
por: Tangen, Gro Gujord, et al.
Publicado: (2012)

Fun and a meaningful routine: the experience of physical activity in people with dementia
por: Telenius, Elisabeth Wiken, et al.
Publicado: (2022)

Association Between Dietary Habits in Midlife With Dementia Incidence Over a 20-Year Period
por: Glans, Isabelle, et al.
Publicado: (2023)

Prevalence and Ascertainment of Dementia Cases in the Malmö Diet and Cancer Study
por: Nägga, Katarina, et al.
Publicado: (2022)

β-amyloid pathology and hippocampal atrophy are independently associated with memory function in cognitively healthy elderly
por: Svenningsson, Anna L., et al.
Publicado: (2019)

Midlife Atherosclerosis and Development of Alzheimer or Vascular Dementia
por: Gustavsson, Anna‐Märta, et al.
Publicado: (2019)

β-Amyloid–Dependent and –Independent Genetic Pathways Regulating CSF Tau Biomarkers in Alzheimer Disease
por: Kumar, Atul, et al.
Publicado: (2022)

Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals
por: Lindberg, Olof, et al.
Publicado: (2017)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

The age-related effect on cognitive performance in cognitively healthy elderly is mainly caused by underlying AD pathology or cerebrovascular lesions: implications for cutoffs regarding cognitive impairment
por: Borland, Emma, et al.
Publicado: (2020)

Axonal degeneration and amyloid pathology predict cognitive decline beyond cortical atrophy
por: Svenningsson, Anna Linnéa, et al.
Publicado: (2022)

(18)F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
por: Smith, Ruben, et al.
Publicado: (2018)

Clinically Relevant Changes for Cognitive Outcomes in Preclinical and Prodromal Cognitive Stages: Implications for Clinical Alzheimer Trials
por: Borland, Emma, et al.
Publicado: (2022)

Cerebellum-Cortical Interaction in Spatial Navigation and Its Alteration in Dementias
por: Mirino, Pierandrea, et al.
Publicado: (2022)

Editorial: Mobility in older adults with cognitive impairment
por: Bogen, Bård, et al.
Publicado: (2023)

Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease–Related Decline
por: Cullen, Nicholas, et al.
Publicado: (2022)

Association of β-Amyloid Accumulation With Executive Function in Adults With Unimpaired Cognition
por: Tideman, Pontus, et al.
Publicado: (2022)

Association Between Earliest Amyloid Uptake and Functional Connectivity in Cognitively Unimpaired Elderly
por: Hahn, Andreas, et al.
Publicado: (2019)

A quick test of cognitive speed can predict development of dementia in Parkinson’s disease
por: Jalakas, Mattis, et al.
Publicado: (2019)

Medial temporal atrophy in preclinical dementia: Visual and automated assessment during six year follow-up
por: Mårtensson, Gustav, et al.
Publicado: (2020)

Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort
por: Tangen, Gro Gujord, et al.
Publicado: (2023)

Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
por: Kumar, Atul, et al.
Publicado: (2021)

DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease
por: Pereira, Joana B., et al.
Publicado: (2023)

Interrater and test-retest reliability and validity of the Norwegian version of the BESTest and mini-BESTest in people with increased risk of falling
por: Hamre, Charlotta, et al.
Publicado: (2017)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
por: Cullen, Nicholas C., et al.
Publicado: (2021)

CSF placental growth factor – a novel candidate biomarker of frontotemporal dementia
por: Hansson, Oskar, et al.
Publicado: (2019)

Prenatal gyrification pattern affects age at onset in frontotemporal dementia
por: Harper, Luke, et al.
Publicado: (2022)

Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Increased mortality risk for adults aged 25–44 years with long-term disability: A prospective cohort study with a 35-year follow-up of 30,080 individuals from 1984–2019 in the population-based HUNT study
por: Langballe, Ellen Melbye, et al.
Publicado: (2022)

Early stages of tau pathology and its associations with functional connectivity, atrophy and memory
por: Berron, David, et al.
Publicado: (2021)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

The implications of different approaches to define AT(N) in Alzheimer disease
por: Mattsson-Carlgren, Niklas, et al.
Publicado: (2020)

Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer’s disease
por: Cullen, Nicholas C, et al.
Publicado: (2023)

Trajectories of physical performance in nursing home residents with dementia
por: Sverdrup, Karen, et al.
Publicado: (2020)

Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer’s disease: a cohort study
por: Mattsson, Niklas, et al.
Publicado: (2018)

Astrocytic function is associated with both amyloid-β and tau pathology in non-demented APOE ϵ4 carriers
por: Spotorno, Nicola, et al.
Publicado: (2022)

Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive Impairment
por: Lindh-Rengifo, Magnus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a1bnmai4erud78q1fu2svvanus